ArticleMalaysian orthopaedic journal2025
Combinational Periprosthetic Hip Joint Infection and Fracture: A Two-Stage Revision with Long Femoral Stem Spacers.
Article in Malaysian orthopaedic journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Management of periprosthetic fractures around cemented femoral stems: osteosynthesis and revision strategies.EFORT open reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Periprosthetic joint infection combined with periprosthetic fracture rarely occurs simultaneously. Once all components of the periprosthetic joint infection were removed, antibiotic spacers were placed. Moreover, periprosthetic fractures require fixing. We use a long femoral stem spacer molded intra-operatively via a self-design metal mold as a novel treatment method for the periprosthetic fracture combined with infection. Material and Methods: The study reviewed 12 patients who underwent two-stage revision arthroplasty with long femoral stem spacers over 6 years. During a minimum of two years of follow-up, the outcomes were evaluated, including reinfection rates, reimplantation rates, and re-operation rates, as well as the success rate based on the MSIS criteria. Results: Twelve patients underwent two-stage revision with a long femoral stem spacer between stages. A mean follow-up period of 9.58 months followed infection (range 2 to 28 months). In 11 patients (91.67%), the infection was eradicated. There was one patient (8.33%) who required a second 2-stage revision and subsequently cleared their infection. The long femoral stem spacer was repeated in three patients (25%). After eradicating the infection, 9 patients (75%) underwent 2nd stage revision, on average 8.56 months after the first stage. At an average of 27.92 months (range 8 - 65 months) post-operatively, three (25%) long femoral stem spacers remained in place. Conclusion: Using long femoral stem spacers, both periprosthetic joint infections and periprosthetic fractures can be treated simultaneously. In the cases with multiple organisms, we mixed one pack of bone cement with 2g of Vancomycin and 2g of Meropenem, resulting in satisfactory results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.